EX-23.1 5 apvo-ex231_599.htm EX-23.1 apvo-ex231_599.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm


We consent to the incorporation by reference in the following Registration Statements:




Registration Statement (Form S-8 No. 333-213108) pertaining to Converted Equity Awards Incentive Plan and 2016 Stock Incentive Plan of Aptevo Therapeutics Inc., and



Registration Statement (Form S-8 No. 333-219875) pertaining to the 2016 Stock Incentive Plan of Aptevo Therapeutics Inc.; and



Registration Statement (Form S-3 No. 333-221499) of Aptevo Therapeutics Inc.


of our report dated March 13, 2018, with respect to the consolidated financial statements of Aptevo Therapeutics Inc. included in this Annual Report (Form 10-K) of Aptevo Therapeutics Inc. for the year ended December 31, 2017.


/s/ Ernst & Young LLP


Seattle, Washington

March 13, 2018